Ianevski, Aleksandr
University of Helsinki · Institute for Molecular Medicine Finland · HiLIFE – Elämäntieteiden Instituutti
6 papers on CoChatORCID 0000-0002-7780-482X
Most cited papers
- Verified
Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity
Dufva, O., Koski, J., Maliniemi, P., Ianevski, A., Klievink, J., Leitner, J., Pölönen, P., Hohtari, H., Saeed, K., Hannunen, T., et al. (2020) · Blood
CAR-T cell therapy researchProtein Degradation and Inhibitors
Cited by 224
- Verified
Breeze: an integrated quality control and data analysis application for high-throughput drug screening
Potdar, S., Ianevski, A., Mpindi, J.-P., Bychkov, D., Fiere, C., Ianevski, P., Yadav, B., Wennerberg, K., Aittokallio, T., Kallioniemi, O., et al. (2020) · Bioinformatics
Computational Drug Discovery MethodsCell Image Analysis Techniques
Cited by 102
- Verified
Drug Combinations as a First Line of Defense against Coronaviruses and Other Emerging Viruses
White, J. M., Schiffer, J. T., Bender Ignacio, R. A., Xu, S., Kainov, D., Ianevski, A., Aittokallio, T., Frieman, M., Olinger, G. G., & Polyak, S. J. (2021) · mBio
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 64
- Verified
Development of HDAC Inhibitors Exhibiting Therapeutic Potential in T-Cell Prolymphocytic Leukemia
Toutah, K., Nawar, N., Timonen, S., Sorger, H., Raouf, Y. S., Bukhari, S., von Jan, J., Ianevski, A., Gawel, J. M., Olaoye, O. O., et al. (2021) · Journal of Medicinal Chemistry
Histone Deacetylase Inhibitors ResearchChronic Lymphocytic Leukemia Research
Cited by 51
- Verified
Computational Drug Repositioning and Experimental Validation of Ivermectin in Treatment of Gastric Cancer
Rabben, H.-L., Andersen, G. T., Ianevski, A., Olsen, M. K., Kainov, D., Grønbech, J. E., Wang, T. C., Chen, D., & Zhao, C.-M. (2021) · Frontiers in Pharmacology
Computational Drug Discovery MethodsGastric Cancer Management and Outcomes
Cited by 24
- Verified
Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia
Adnan Awad, S., Dufva, O., Klievink, J., Karjalainen, E., Ianevski, A., Pietarinen, P., Kim, D., Potdar, S., Wolf, M., Lotfi, K., et al. (2024) · Cell Reports Medicine
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free